Economic benefits of methylmercury exposure control in Europe: Monetary value of neurotoxicity prevention

Philippe Grandjean(University of Rhode Island), Argelia Castaño(Instituto de Salud Carlos III), Janja Snoj Tratnik(Jožef Stefan Institute), Marta Esteban(Instituto de Salud Carlos III), Marike Kolossa‐Gehring(German Environment Agency), Andromachi Katsonouri(University of Copenhagen), M. Fátima Reis(Orszagos Kornyezetegeszsegugyi Intezet), Katarína Halzlová(Nicosia General Hospital), Gudrun Koppen(Flemish Institute for Technological Research), Céline Pichery(École des Hautes Études en Santé Publique), Danuta Ligocka(Nofer Institute of Occupational Medicine), Anca Elena Gurzău(Public Health Authority of the Slovak Republic), Pál Weihe(University of the Faroe Islands), Marc Fischer(Laboratoire National de Santé), Ana Miklavčič Višnjevec(University of Primorska), Lisbeth E. Knudsen(University of Copenhagen), Esben Budtz–Jørgensen(University of Copenhagen), Dominique Aerts(Directorate-General for Health and Food Safety), Mája Čejchanová(Federal Department of Home Affairs), Pierre Crettaz(Federal Department of Home Affairs), Marika Berglund(Instituto de Salud Carlos III), Péter Rudnai(Orszagos Kornyezetegeszsegugyi Intezet), Fred Davidson(Instituto de Salud Carlos III), M. Bellanger(École des Hautes Études en Santé Publique)
Environmental Health
January 7, 2013
Cited by 167


Related Papers